Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
GHK-Cu injections deliver the copper peptide complex directly into targeted tissues typically via subcutaneous injection
What GLP-1 Support Can Do for Your Weight Loss Journey GLP-1 support can be an effective part of a medically guided weight loss program when paired with nutrition, movement, and ongoing coaching
According to the National Institute of Health, glutathione is a tripeptide that includes glutamic acid and cysteinylglycine
Many in the bodybuilding industry will know that show prep can often affect sexual desires and function